Literature DB >> 324370

The current status of BCG immunization against tuberculosis.

T C Eickhoff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 324370     DOI： 10.1146/annurev.me.28.020177.002211

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN： 0066-4219            Impact factor:   13.739


× No keyword cloud information.
  10 in total

1.  Does BCG vaccine prevent tuberculous meningitis?

Authors:  N Thilothammal; P V Krishnamurthy; D K Runyan; K Banu
Journal:  Arch Dis Child       Date:  1996-02       Impact factor: 3.791

2.  A case-control study to evaluate the effectiveness of mass neonatal BCG vaccination among Canadian Indians.

Authors:  T K Young; E S Hershfield
Journal:  Am J Public Health       Date:  1986-07       Impact factor: 9.308

3.  In vitro culture medium influences the vaccine efficacy of Mycobacterium bovis BCG.

Authors:  Manjunatha M Venkataswamy; Michael F Goldberg; Andres Baena; John Chan; William R Jacobs; Steven A Porcelli
Journal:  Vaccine       Date:  2011-12-18       Impact factor: 3.641

4.  The Type of Growth Medium Affects the Presence of a Mycobacterial Capsule and Is Associated With Differences in Protective Efficacy of BCG Vaccination Against Mycobacterium tuberculosis.

Authors:  Rafael Prados-Rosales; Leandro J Carreño; Brian Weinrick; Ana Batista-Gonzalez; Aarona Glatman-Freedman; Jiayong Xu; John Chan; William R Jacobs; Steven A Porcelli; Arturo Casadevall
Journal:  J Infect Dis       Date:  2016-04-18       Impact factor: 5.226

5.  Effect of route of Mycobacterium bovis BCG administration on induction of suppression of sporozoite immunity in rodent malaria.

Authors:  L L Smrkovski
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

6.  Exploring the Potential Role of Moonlighting Function of the Surface-Associated Proteins From Mycobacterium bovis BCG Moreau and Pasteur by Comparative Proteomic.

Authors:  Talita Duarte Pagani; Ana Carolina R Guimarães; Mariana C Waghabi; Paloma Rezende Corrêa; Dário Eluan Kalume; Marcia Berrêdo-Pinho; Wim Maurits Degrave; Leila Mendonça-Lima
Journal:  Front Immunol       Date:  2019-04-26       Impact factor: 7.561

7.  Each Mycobacterium Requires a Specific Culture Medium Composition for Triggering an Optimized Immunomodulatory and Antitumoral Effect.

Authors:  Sandra Guallar-Garrido; Víctor Campo-Pérez; Alejandro Sánchez-Chardi; Marina Luquin; Esther Julián
Journal:  Microorganisms       Date:  2020-05-14

8.  Nonspecific resistance to bacterial infections. Enhancement by ubiquinone-8.

Authors:  L H Block; A Georgopoulos; P Mayer; J Drews
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

9.  Tularemia vaccine development: paralysis or progress?

Authors:  Raju Sunagar; Sudeep Kumar; Brian J Franz; Edmund J Gosselin
Journal:  Vaccine (Auckl)       Date:  2016-05-04

10.  Vaccines Directed Against Microorganisms or Their Products Present During Biofilm Lifestyle: Can We Make a Translation as a Broad Biological Model to Tuberculosis?

Authors:  Mario A Flores-Valdez
Journal:  Front Microbiol       Date:  2016-01-21       Impact factor: 5.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.